Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; and research and development of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Key Metrics
as of Sep 2026
Market Cap 96,072 Cr
P/E 29.80
Div Yield 0.70 %
Book Value βΉ454.00
52w High βΉ1,415.00
52w Low βΉ1,080.00
Face Value βΉ1.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
8,100.00
7,546.00
8,753.00
8,828.00
8,572.00
8,528.00
8,381.00
8,038.00
7,696.00
7,114.00
7,237.00
6,903.00
6,758.00
Expenses
7,240.00
7,164.00
6,866.00
6,818.00
6,398.00
6,530.00
6,108.00
5,962.00
5,566.00
5,283.00
5,214.00
4,894.00
4,696.00
Operating Profit
860.00
382.00
1,888.00
2,010.00
2,174.00
1,998.00
2,273.00
2,076.00
2,130.00
1,831.00
2,023.00
2,008.00
2,062.00
OPM %
11.00
5.00
22.00
23.00
25.00
23.00
27.00
26.00
28.00
26.00
28.00
29.00
31.00
Other Income
356.00
480.00
271.00
330.00
290.00
528.00
154.00
314.00
193.00
201.00
219.00
319.00
178.00
Depreciation
537.00
557.00
521.00
505.00
476.00
455.00
471.00
397.00
381.00
368.00
374.00
376.00
353.00
Interest
126.00
106.00
94.00
91.00
83.00
66.00
82.00
76.00
60.00
59.00
39.00
35.00
37.00
Profit before tax
553.00
200.00
1,543.00
1,745.00
1,905.00
2,005.00
1,874.00
1,917.00
1,883.00
1,605.00
1,829.00
1,917.00
1,850.00
Tax %
21.00
-11.00
23.00
23.00
26.00
21.00
25.00
30.00
26.00
18.00
24.00
23.00
24.00
Net Profit
436.00
221.00
1,190.00
1,337.00
1,410.00
1,587.00
1,404.00
1,342.00
1,392.00
1,310.00
1,381.00
1,482.00
1,405.00
EPS in Rs
5.32
2.65
14.50
16.14
16.99
19.09
16.94
15.05
16.69
15.70
16.56
17.77
16.87
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
33,700.00 32,644.00 28,011.00 24,670.00 21,545.00 19,048.00 17,517.00 15,448.00 14,281.00 14,196.00 15,568.00 15,023.00
Expenses
27,247.00 24,097.00 20,078.00 18,200.00 17,778.00 15,173.00 15,040.00 12,270.00 11,930.00 11,724.00 11,983.00 11,515.00
Operating Profit
6,454.00 8,547.00 7,933.00 6,470.00 3,768.00 3,874.00 2,477.00 3,178.00 2,351.00 2,472.00 3,585.00 3,508.00
OPM %
19.00 26.00 28.00 26.00 17.00 20.00 14.00 21.00 16.00 17.00 23.00 23.00
Other Income
1,372.00 1,119.00 909.00 971.00 555.00 335.00 670.00 381.00 155.00 172.00 295.00 260.00
Interest
374.00 283.00 171.00 143.00 96.00 97.00 98.00 89.00 79.00 63.00 83.00 108.00
Depreciation
2,059.00 1,704.00 1,470.00 1,250.00 1,165.00 1,229.00 1,163.00 1,135.00 1,077.00 1,027.00 939.00 760.00
Profit before tax
5,393.00 7,680.00 7,201.00 6,048.00 3,061.00 2,884.00 1,886.00 2,336.00 1,350.00 1,554.00 2,859.00 2,900.00
Tax %
23.00 25.00 23.00 25.00 29.00 32.00 -7.00 17.00 32.00 19.00 26.00 19.00
Net Profit
4,158.00 5,725.00 5,578.00 4,507.00 2,182.00 1,952.00 2,026.00 1,950.00 947.00 1,292.00 2,131.00 2,336.00
EPS in Rs
50.27 67.77 66.87 54.14 26.23 23.47 24.38 23.49 11.41 15.59 24.98 27.43
Dividend Payout %
16.00 12.00 12.00 15.00 23.00 21.00 21.00 17.00 35.00 26.00 16.00 15.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
84.00 83.00 83.00 83.00 83.00 83.00 83.00 83.00 83.00 83.00 85.00 85.00
Reserves
37,808.00 33,466.00 28,171.00 23,203.00 19,129.00 17,558.00 15,516.00 13,941.00 12,489.00 12,179.00 12,484.00 9,768.00
Borrowings
7,734.00 4,677.00 2,002.00 1,347.00 3,384.00 3,031.00 2,210.00 3,838.00 5,071.00 4,918.00 3,352.00 4,314.00
Other Liabilities
10,951.00 9,797.00 8,523.00 7,576.00 7,149.00 5,915.00 5,414.00 4,557.00 4,706.00 4,474.00 4,408.00 4,290.00
Total Liabilities
56,577.00 48,023.00 38,780.00 32,209.00 29,746.00 26,588.00 23,223.00 22,418.00 22,349.00 21,654.00 20,330.00 18,457.00
Fixed Assets
22,063.00 18,226.00 10,426.00 9,219.00 8,122.00 8,206.00 6,850.00 7,191.00 6,968.00 6,931.00 6,563.00 5,377.00
CWIP
1,460.00 2,466.00 1,419.00 1,030.00 1,293.00 1,565.00 1,535.00 2,934.00 3,470.00 3,324.00 772.00 529.00
Investments
5,285.00 4,051.00 4,930.00 4,986.00 2,616.00 2,212.00 2,678.00 2,587.00 2,298.00 2,110.00 3,833.00 2,248.00
Other Assets
27,768.00 23,280.00 22,004.00 16,974.00 17,715.00 14,605.00 12,160.00 9,707.00 9,612.00 9,290.00 9,162.00 10,303.00
Total Assets
56,577.00 48,023.00 38,780.00 32,209.00 29,746.00 26,588.00 23,223.00 22,418.00 22,349.00 21,654.00 20,330.00 18,457.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
5,674.00 4,643.00 4,543.00 5,888.00 2,811.00 3,570.00 2,984.00 2,870.00 1,803.00 2,144.00 3,263.00 2,524.00
Cash from Investing Activity
-6,425.00 -5,785.00 -4,034.00 -4,109.00 -2,565.00 -2,255.00 -495.00 -769.00 -1,483.00 -1,890.00 -1,610.00 -2,370.00
Cash from Financing Activity
829.00 1,891.00 -376.00 -2,686.00 -242.00 -30.00 -2,516.00 -2,133.00 -444.00 -369.00 -1,700.00 -433.00
Net Cash Flow
78.00 749.00 133.00 -907.00 3.00 1,286.00 -27.00 -31.00 -124.00 -114.00 -47.00 -280.00
Free Cash Flow
2,004.00 1,327.00 1,908.00 4,009.00 1,238.00 2,323.00 2,412.00 2,248.00 713.00 926.00 2,065.00 1,009.00
CFO/OP %
109.00 78.00 83.00 108.00 94.00 107.00 149.00 106.00 88.00 110.00 111.00 88.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
110.00 101.00 105.00 107.00 113.00 95.00 105.00 94.00 104.00 98.00 97.00 100.00
Inventory Days
228.00 260.00 283.00 232.00 250.00 273.00 230.00 273.00 263.00 282.00 248.00 248.00
Days Payable
91.00 97.00 116.00 108.00 111.00 109.00 100.00 111.00 121.00 104.00 88.00 84.00
Cash Conversion Cycle
247.00 264.00 271.00 231.00 252.00 259.00 235.00 256.00 246.00 275.00 257.00 264.00
Working Capital Days
68.00 69.00 118.00 84.00 61.00 57.00 59.00 65.00 39.00 -14.00 34.00 26.00
ROCE %
13.00 23.00 27.00 27.00 14.00 16.00 11.00 13.00 8.00 9.00 19.00 22.00
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
26.63
26.63
26.64
26.64
26.64
26.64
26.64
26.64
26.65
26.65
26.65
26.66
FIIs
20.67
21.14
22.34
24.69
25.33
25.75
26.85
27.53
27.68
29.13
28.62
28.19
DIIs
31.75
30.72
30.44
27.99
26.73
25.63
22.89
21.48
20.72
18.31
18.65
21.04
Public
20.76
21.27
20.33
20.45
21.04
21.69
23.46
24.20
24.78
25.73
25.89
23.93
No. of Shareholders
446,086
449,665
455,243
449,216
451,929
459,605
403,669
310,403
267,694
255,500
257,794
243,445
Corporate Actions
30 records
Back to all stocks